Orchid Pharma's Alathur API facility successfully completes US FDA inspection: Our Bureau, Mumbai Thursday, February 20, 2025, 11:30 Hrs [IST] Orchid Pharma Ltd., a vertically int ...

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of its new sterile manufacturing facility in Nottingham, UK. The new facility ...

Orchid Pharma's Alathur facility is the only U.S. FDA-approved manufacturing site in India for sterile cephalosporins, a ...

If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.

Upperton Pharma Solutions has taken a £7m leap forward with the launch of its new sterile manufacturing facility in Nottingham. Adding to its existing 50,000 sq ft Trent Gateway site, the purpose ...

The US FDA conducted an inspection at Orchid Pharma's Active Pharmaceutical Ingredient (API) manufacturing facility in ...

U.K.-based CDMO Upperton Pharma Solutions expanded its production footprint with the completion of a new £7 million ($8.1 million) sterile manufacturing facility at its Nottingham campus.

Orchid Pharma Ltd., a vertically integrated pharmaceutical company, has received seven minor observations from the U.S. Food ...

"The inspection, which commenced on 10 February 2025 and concluded on 18 February 2025, resulted in seven minor observations, ...

Orchid Pharma added 1.96% to Rs 851 after company completed an inspection by the U.S. Food and Drug Administration (USFDA) at its active pharmaceutical ingredient (API) manufacturing facility in ...